glp-1 hormone GLP-1: Actions on Beta-cell Mass and Function Health Feed - Glp-1 Drugs

The US Food and Drug Administration only approved exenatide to treat type-2 diabetes in 2005

Individual factors and clinical context should guide any decisions

Patients with: Personal or family history of Medullary thyroid cancer MEN2 syndrome Severe gastroparesis Pregnancy/ breastfeeding Pancreatitis or breastfeeding Severe depression Eating disorders Liver or kidney disease (caution advised) Why GLP-1 and Inflammation and Arthritis Matter We now understand that GLP-1 medications are not just weight loss drugs. They are anti-inflammatory, immune-modulating, metabolic medications that can dramatically shift health outcomes for patients with arthritis and autoimmune diseases

Role of Baseline Gut Microbiota on Response to Fiber Intervention in Individuals with Irritable Bowel Syndrome

323,324,325 Specifically, activation of GLP-1R leads to an increase in cAMP levels, which in turn activates PKA, a widely regulating enzyme of cellular functions, capable of phosphorylating a variety of target proteins, thereby initiating the PKA/CREB signaling pathway